Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy

Pediatrics

Volumn 109, Issue 2 I, 2002, Pages 322-325

  Robson, William Lane M ^a   Tsai, Han Mou ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CENTROMERE ANTIBODY; CORTICOSTEROID; CREATININE; DNA ANTIBODY; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; METALLOPROTEINASE; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROTEINASE INHIBITOR; VON WILLEBRAND FACTOR;

ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; ENZYME ACTIVITY; HEMOLYTIC UREMIC SYNDROME; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; CHILD; DIAGNOSIS, DIFFERENTIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; METALLOENDOPEPTIDASES; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0036159297     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.2.322     Document Type: Article

References (22)

1. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
2. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
3. Antibodies to Von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
4. Moschcowitz, multimers and metalloprotease
5. Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
6. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease
7. Von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic
8. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura
9. Pathological features of thrombotic thrombocytopenic purpura
10. Congenital microangiopathic haemolytic anemia: A variant of thrombotic thrombocytopenic purpura?
11. HUS and TTP: Variable expression of a single entity
12. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
13. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells
14. Flow-related platelet deposition on subendothelium
15. Role of von Willebrand factor in platelet thrombus formation
16. Shear-dependent changes in the three dimensional structure of human von Willebrand factor
17. Antibody inhibitors to von Willebrand factor metalloproteinase and increased von Willebrand factor-platelet binding in ticlopidine-associated thrombotic thrombocytopenic purpura
18. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura
19. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
20. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
21. Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasma exchange and vincristine
22. Thrombotic thrombocytopenic purpura: A treatable cause of childhood encephalopathy